Literature DB >> 9345279

Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells.

H Satoh1, M Togo, M Hara, T Miyata, K Han, H Maekawa, M Ohno, Y Hashimoto, K Kurokawa, T Watanabe.   

Abstract

Advanced glycation end products of bovine serum albumin (AGEs-BSA) exhibited biphasic effects on the proliferation of cultured rabbit vascular smooth muscle cells (VSMCs) in terms of [3H]thymidine incorporation and cell number count; a stimulatory effect was observed at 1-10 micrograms/ml and an inhibitory effect at more than 20 micrograms/ml, while it inhibited [3H]thymidine incorporation even at 1-10 micrograms/ml in cultured bovine vascular endothelial cells (VECs). Transient activation of p42 mitogen-activated protein kinase (MAPK) with a peak at around 5 min and a subsequent sustained phase was induced by AGEs-BSA in VSMCs, but not in VECs. The dependence of MAPK activation on AGEs-BSA dose was correlated with that of VSMCs proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345279     DOI: 10.1006/bbrc.1997.7424

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

Authors:  Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

2.  Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.

Authors:  Hong-Zheng Meng; Wei-Lin Zhang; Fei Liu; Mao-Wei Yang
Journal:  J Biol Chem       Date:  2015-10-15       Impact factor: 5.157

3.  Intrauterine hyperglycemia-induced inflammatory signalling via the receptor for advanced glycation end products in the cardiac muscle of the infants of diabetic mother rats.

Authors:  Ritsuko Kawaharada; Haruna Masuda; Zhenyi Chen; Eric Blough; Tomoko Kohama; Akio Nakamura
Journal:  Eur J Nutr       Date:  2017-09-23       Impact factor: 5.614

4.  Advanced glycation end products promote proliferation and suppress autophagy via reduction of Cathepsin D in rat vascular smooth muscle cells.

Authors:  Mingfeng Ma; Xiaofan Guo; Ye Chang; Chao Li; Xin Meng; Si Li; Zhen-Xian Du; Hua-Qin Wang; Yingxian Sun
Journal:  Mol Cell Biochem       Date:  2015-02-12       Impact factor: 3.396

5.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

6.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

7.  Tropoelastin modulates TGF-β1-induced expression of VEGF and CTGF in airway smooth muscle cells.

Authors:  Caroline J Reddel; Daniele Cultrone; Jelena Rnjak-Kovacina; Anthony S Weiss; Janette K Burgess
Journal:  Matrix Biol       Date:  2013-04-15       Impact factor: 11.583

8.  Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products.

Authors:  A Schmidt; B Kuhla; K Bigl; G Münch; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

9.  Nonenzymatic glycation interferes with fibronectin-integrin interactions in vascular smooth muscle cells.

Authors:  Srijita Dhar; Zhe Sun; Gerald A Meininger; Michael A Hill
Journal:  Microcirculation       Date:  2017-04       Impact factor: 2.628

Review 10.  Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.

Authors:  Sunil S Adav; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-11-03       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.